These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21607331)

  • 21. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
    Shaib W; Lee V; Saif MW
    In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of 5-fluorouracil on contractility and oxygen uptake of the isolated perfused rat heart.
    Millart H; Brabant L; Lorenzato M; Lamiable D; Albert O; Choisy H
    Anticancer Res; 1992; 12(2):571-6. PubMed ID: 1580574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
    Jensen SA; Sørensen JB
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptomatic 5-fluorouracil-induced sinus bradycardia.
    Lee AD; McKay MJ
    Intern Med J; 2011 Jul; 41(7):566-70. PubMed ID: 21762335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 31P NMR spectroscopy and polarographic combined study of erythrocytes treated with 5-fluorouracil: cardiotoxicity-related changes in ATP, 2,3-BPG, and O2 metabolism.
    Spasojević I; Zakrzewska J; Bacić GG
    Ann N Y Acad Sci; 2005 Jun; 1048():311-20. PubMed ID: 16154943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinal toxicity of intravitreal 5-fluorouracil in silicone-filled rabbit eyes.
    Kivilcim M; Kazi AA; Peyman GA; Hegazy H; El Dessouky el-S; Cheema R; Laghari NA
    J Coll Physicians Surg Pak; 2006 May; 16(5):351-4. PubMed ID: 16756781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil.
    Eskilsson J; Albertsson M
    Acta Oncol; 1990; 29(8):1001-3. PubMed ID: 2278719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells.
    Safwat MA; Soliman GM; Sayed D; Attia MA
    Int J Pharm; 2016 Nov; 513(1-2):648-658. PubMed ID: 27693737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of Heart-Type Fatty Acid-Binding Protein and Myocardial Performance Index for Early Detection of 5-Fluorouracil Cardiotoxicity.
    Turan T; Agac MT; Aykan AÇ; Kul S; Akyüz AR; Gökdeniz T; Gül İ; Cengiz E; Boyacı F; Erkan H; Akdemir R; Celik S
    Angiology; 2017 Jan; 68(1):52-58. PubMed ID: 26980771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiotoxicity of 5-fluorouracil].
    Pan L; Yang X; Song H
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):86-9. PubMed ID: 8758800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity.
    Jensen SA; Sørensen JB
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):57-64. PubMed ID: 21603868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of the antitumor activity of 5-fluorouracil by (R)-5-fluoro-5,6-dihydrouracil.
    Spector T; Cao S; Rustum YM; Harrington JA; Porter DJ
    Cancer Res; 1995 Mar; 55(6):1239-41. PubMed ID: 7882316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The need for routine monitoring of cardiac function in patients receiving 5-fluorouracil infusion.
    Francis N
    Clin J Oncol Nurs; 2014 Jun; 18(3):360-2. PubMed ID: 24867118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro and in-vivo assessment of dextran-appended cellulose acetate phthalate nanoparticles for transdermal delivery of 5-fluorouracil.
    Garg A; Rai G; Lodhi S; Jain AP; Yadav AK
    Drug Deliv; 2016 Jun; 23(5):1525-35. PubMed ID: 25417834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgery.
    Einmahl S; Behar-Cohen F; D'Hermies F; Rudaz S; Tabatabay C; Renard G; Gurny R
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):695-700. PubMed ID: 11222529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles.
    Stutchbury TK; Vine KL; Locke JM; Chrisp JS; Bremner JB; Clingan PR; Ranson M
    Anticancer Drugs; 2011 Jan; 22(1):24-34. PubMed ID: 20881836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
    Puri R; Jain S
    Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiotoxicity of 5-fluorouracil: report of 6 cases].
    Timour Q; Lombard-Bohas C; Slim R; Barel C; Bui-Xuan B; Tabib A; Bricca G; Malonne H; Vial T; Iordescu D; Descotes J
    Therapie; 2002; 57(3):302-6. PubMed ID: 12422546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of uracil on metabolism of 5-fluorouracil in vitro.
    Ikenaka K; Shirasaka T; Kitano S; Fujii S
    Gan; 1979 Jun; 70(3):353-9. PubMed ID: 467897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.